Sponsor:
Reviva Pharmaceuticals
Code:
NCT05184335
Conditions
Schizophrenia
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Accepted
Interventions
Brilaroxazine
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-30. This information was provided to ClinicalTrials.gov by Reviva Pharmaceuticals on 2024-12-19.